【レポートの概要（一部）】
Table of Content
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumption
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Optical Imaging System Market – Industry Snapshot and Key Buying Criteria, 2015
Chapter 3. Optical Imaging System Industry Outlook
3.1. Market Segmentation
3.2. Optical Imaging System Market Size and Growth Prospects
3.3. Optical Imaging System Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Rising prevalence of ophthalmic disorders
3.3.1.2. Technological advancements
3.3.1.3. Increasing preference for noninvasive technology
3.3.1.4. Widening areas of application
3.3.2. Market Restraint Analysis
3.3.2.1. Lack of Skilled Operators
3.3.2.2. High Cost and Data Requirement
3.4. Key Opportunities Prioritized
3.5. Industry Analysis -Porter’s
3.6. Optical Imaging System Market PESTEL Analysis, 2015
Chapter 4. Optical Imaging System Market by Technology
4.1. Optical Imaging System Market Share, by Technology, 2015 & 2024 (USD Million)
4.2. Photoacoustic Tomography
4.2.1. Photoacoustic Tomography Market Estimates & Forecasts, 2013 – 2024 (USD Million)
4.3. Optical Coherence Tomography
4.3.1. Optical Coherence Tomography Market Estimates and Forecasts, 2013 – 2024 (USD Million)
4.4. Hyperspectral Imaging
4.4.1. Hyperspectral Imaging Market Estimates and Forecasts, 2013 – 2024 (USD Million)
4.5. Near-Infrared Spectroscopy
4.5.1. Near-Infrared Spectroscopy Market Estimates & Forecasts, 2013 – 2024 (USD Million)
Chapter 5. Optical Imaging System Market by Product
5.1. Optical Imaging System Market Share, by Product, 2015 & 2024 (USD Million)
5.2. Imaging Systems
5.2.1. Imaging Systems Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.2.1.1. Optical imaging systems market estimates & forecasts, 2013 – 2024 (USD Million)
5.2.1.2. Spectral imaging systems Market estimates & forecasts, 2013 – 2024 (USD Million)
5.3. Optical Imaging Software
5.3.1. Optical Imaging Software Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.4. Cameras
5.4.1. Cameras Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.5. Illumination Systems
5.5.1. Illumination Systems Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.6. Lenses
5.6.1. Lenses Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.7. Other Optical Imaging Products
5.7.1. Other Optical Imaging Products Market Estimates and Forecasts, 2013 – 2024 (USD Million)
Chapter 6. Optical Imaging System Market by Application
6.1. Optical Imaging System Market Share, by Application, 2015 & 2024 (USD Million)
6.2. Pathological Imaging
6.2.1. Pathological Imaging Market Estimates and Forecasts, 2013 – 2024 (USD Million)
6.3. Intraoperative Imaging
6.3.1. Intraoperative Imaging Market Estimates and Forecasts, 2013 – 2024 (USD Million)
Chapter 7. Optical Imaging System Market by End Use
7.1. Optical Imaging System Market Share, by End Use,2015 & 2024 (USD Million)
7.2. Research Laboratories
7.2.1. Research Laboratories Market Estimates and Forecasts, 2013 – 2024 (USD Million)
7.3. Hospitals & Clinics
7.3.1. Hospital & Clinics Market Estimates and Forecasts, 2013 – 2024 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
7.4.1. Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2013 – 2024 (USD Million)
Chapter 8. Optical Imaging System Market by Therapeutic Area
8.1. Optical Imaging System Market Share, by Therapeutic Area, 2015 & 2024 (USD Million)
8.2. Ophthalmology
8.2.1. Ophthalmology Market Estimates and Forecasts, 2013 -2024 (USD Million)
8.3. Cardiology
8.3.1. Cardiology Market Estimates and Forecasts, 2013 – 2024 (USD Million)
8.4. Oncology
8.4.1. Oncology Market Estimates and Forecasts, 2013 – 2024 (USD Million)
8.5. Dermatology
8.5.1. Dermatology Market Estimates and Forecasts, 2013 – 2024 (USD Million)
8.6. Neurology
8.6.1. Neurology Market Estimates and Forecasts, 2013 – 2024 (USD Million)
Chapter 9. Optical Imaging System Market by Region
9.1. Optical Imaging System Market Share, by Region,2015 & 2024 (USD Million)
9.2. North America
9.2.1. North America Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.2.2. U.S.
9.2.2.1. U.S. Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.2.2.2. U.S. Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.2.2.3. U.S. Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.2.2.4. U.S. Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.2.2.5. U.S. Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.2.2.6. U.S. Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
9.2.3. Canada
9.2.3.1. Canada Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.2.3.2. Canada Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.2.3.3. Canada Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.2.3.4. Canada Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.2.3.5. Canada Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.2.3.6. Canada Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
9.3. Europe
9.3.1. Europe Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.3.2. UK
9.3.2.1. UK Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.3.2.2. UK Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.3.2.3. UK Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.3.2.4. UK Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.3.2.5. UK Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.3.2.6. UK Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
9.3.3. Germany
9.3.3.1. Germany Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.3.3.2. Germany Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.3.3.3. Germany Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.3.3.4. Germany Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.3.3.5. Germany Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.3.3.6. Germany Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.4.2. Japan
9.4.2.1. Japan Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.4.2.2. Japan Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.4.2.3. Japan Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.4.2.4. Japan Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.4.2.5. Japan Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.4.2.6. Japan Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
9.4.3. China
9.4.3.1. China Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.4.3.2. China Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.4.3.3. China Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.4.3.4. China Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.4.3.5. China Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.4.3.6. China Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
9.5. Latin America
9.5.1. Latin America Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.5.2. Brazil
9.5.2.1. Brazil Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.5.2.2. Japan Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.5.2.3. Brazil Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.5.2.4. Brazil Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.5.2.5. Brazil Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.5.2.6. Brazil Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
9.5.3. Mexico
9.5.3.1. Mexico Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.5.3.2. Mexico Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.5.3.3. Mexico Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.5.3.4. Mexico Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.5.3.5. Mexico Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.5.3.6. Mexico Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
9.6. MEA
9.6.1. MEA Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.6.2. South Africa
9.6.2.1. South Africa Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.6.2.2. South Africa Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.6.2.3. South Africa Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.6.2.4. South Africa Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.6.2.5. South Africa Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.6.2.6. South Africa Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Saudi Arabia Market Estimates and Forecasts, 2013 – 2024 (USD Million)
9.6.3.2. Saudi Arabia Market Estimates and Forecasts by Technology 2013 – 2024 (USD Million)
9.6.3.3. Saudi Arabia Market Estimates and Forecasts by Product 2013 – 2024 (USD Million)
9.6.3.4. Saudi Arabia Market Estimates and Forecasts by Application 2013 – 2024 (USD Million)
9.6.3.5. Saudi Arabia Market Estimates and Forecasts by End Use 2013 – 2024 (USD Million)
9.6.3.6. Saudi Arabia Market Estimates and Forecasts by Therapeutic Area 2013 – 2024 (USD Million)
Chapter 10. Competitive Landscape
10.1. St. Jude Medical, Inc.
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiatives
10.2. PerkinElmer, Inc.
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Strategic Initiatives
10.3. Koninklijke Philips
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Strategic Initiatives
10.4. Carl Zeiss Meditec AG
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Strategic Initiatives
10.5. Topcon Corporation
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Strategic Initiatives
10.6. Bioptigen, Inc.
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Strategic Initiatives
10.7. Canon, Inc.
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Strategic Initiatives
10.8. Heidelberg Engineering, Inc.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Strategic Initiatives
10.9. Optovue, Inc.
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Strategic Initiatives
10.10. Headwall Photonics, Inc.
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Strategic Initiatives
【レポート販売概要】
■ タイトル：光学イメージングシステムの世界市場分析：技術別（光音響トモグラフィ、光干渉断層撮影、ハイパースペクトル画像化、近赤外分光法）、製品別（イメージングシステム、光学イメージングソフトウェア、カメラ、照明システム、レンズ）、用途別（病理イメージング、術中イメージング）、エンドユーザー別、治療分野別（眼科、心臓病、腫瘍学、皮膚科、神経学）、セグメント予測■ 英文：Optical Imaging System Market Analysis By Technology (Photoacoustic Tomography, Optical Coherence Tomography, Hyperspectral Imaging, Near-infrared Spectroscopy), By Product (Imaging Systems, Optical Imaging Software, Cameras, Illumination Systems, Lenses), By Application (Pathological Imaging, Intraoperative Imaging), By End Use , By Therapeutic Area (Ophthalmology, Cardiology, Oncology, Dermatology, Neurology) And Segment Forecasts To 2024
■ 発行日：2015年10月1日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707616
■ 調査対象地域：グローバル
- バイオ燃料市場に関する理解：Understanding BiofuelsThe topic of biofuels has drawn increased interest worldwide in the wake of steeply-climbing fossil fuel prices in 2005-2006. In late 2006/early 2007 prices began to subside, but are unlikely to return to their former levels. The painful experience of national economies at the mercy of decisions taken far from their shores left a lasting impression on policymakers, and many nations now have a stro …
- 精密畜産農業（PLF）の世界市場分析及び予測（2019年-2024年）Precision livestock farming market anticipated growing at CAGR of 9.2% from 2019 to 2024The precision livestock farming market is estimated to be worth USD 3.0 billion in 2019 and is expected to reach USD 4.6 billion by 2024, at a CAGR of 9.2% from 2019 to 2024. The major drivers for the precision livestock farming market are increasing consolidation of livestock farms, increasing herd size of dai …
- 世界のポリプロピレン市場：需要、キャパシティ、価格Global Demand, Capacity and Prices for Polypropylene - End-Use Sectors in Asia-Pacific to Drive Growth Summary GlobalData, the industry analysis specialist, has released its latest research, “Global Demand, Capacity and Prices for Polypropylene - End-Use Sectors in Asia-Pacific to Drive Growth”. The study comes from the company’s oil and gas research group and provides market analysis of the globa …
- 世界のデータセンター冷却市場（技術進歩、予測、分析）Data Center Cooling refers to the management and maintenance of data center temperature, in a way ensuring efficient and cost-effective operation of a data center. In this report, data center cooling not only refers to the traditional air conditioning of the data centers, but also includes various emerging cooling technologies, advanced cooling hardware, cooling management systems and the cooling …
- 世界のスペシャリティケミカルズ市場（2014-2018）TechNavio's analysts forecast the Global Specialty Chemicals market to grow at a CAGR of 5.16 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing demand for specialty chemicals products in the rapidly developing countries of the APAC region. The Global Specialty Chemicals market has also been witnessing the increase in mergers and acquisition …
- 世界の希少疾病用医薬品市場動向（～2020）Orphan drugs, also called niche busters, are intended to treat patients suffering from very serious diseases for which no treatment or at least a satisfactory one, has so far been available. These diseases, often referred to as orphan diseases or rare diseases, affect only a small portion of the population. The number of diseases for which no treatment is currently available is estimated to be bet …
- 医療用外骨格の世界市場：種類別、地域別Global Medical Exoskeleton Market: About this market Technavio’s medical exoskeleton market analysis considers sales from mobile exoskeleton and stationary exoskeleton. Our study also finds the sales of the medical exoskeleton in Asia, Europe, North America, and ROW. In 2019, the mobile exoskeleton segment had a significant market share, and this trend is expected to continue over the forecast per …
- ハイパースペクトルイメージング（HSI）の世界市場2016-2020About the Hyperspectral Imaging (HSI) Market Hyperspectral refers to the number of bands into which the spectrum is divided. Before HSI, multispectral imaging (which divides the spectrum into a few bands) was common. An HSI sensor is the key component for HSI. It converts the light received from objects into electrical signals. This is achieved with the help of the following components: • Lenses, …
- 等温核酸増幅技術（INAAT）のグローバル市場（～2018）The isothermal nucleic acid amplification technology (INAAT) market is poised to reach $1,651 million by 2018 at a CAGR of 13.5% during the forecast period. Though PCR technology dominates the nucleic acid amplification technology market currently, adoption of INAAT technology is expected to be significant in coming years as it offers better clinical results in detecting pathogens during point-of- …
- グローバルセイボリースナック 市場におけるM&A動向（2014年3月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global savory snacks market during March 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global savory snacks market throughout the month. Additionally, the report provides an overview of all th …
- ナイロンモノフィラメントの世界市場分析：製品別（ナイロン6、ナイロン66）、用途別（漁網、医療、自動車、消費財）、セグメント予測、-2020The global nylon monofilaments market is expected to reach USD 1.89 billion by 2020. Growth of key end-use industries such as automotive, fishing and consumer good in Asia Pacific and Latin America is expected to remain a key driving factor for the global nylon monofilament market. Growing nylon monofilament application development in medical industry is also expected to have a positive impact on …
- グリオキサールの世界市場分析：用途別（繊維、皮革、樹脂・ポリマー、化粧品、製紙包装、石油・ガス）、セグメント予測The global glyoxal market is expected to reach USD 2.60 billion by 2024, according to a new report by Grand View Research, Inc. Increasing oil & gas exploration and production activities in Asia Pacific and the Middle East are anticipated to drive global market. Global glyoxal industry is expected to witness a significant growth over the forecast period on account of its wide application scope acr …
- GTL(Gas to Liquids)のグローバル市場動向In the wake of the rising pollution levels due to the emissions traditionally associated with conventional petroleum-fuelled and diesel-fuelled vehicles, Gas to liquids technology is forecast to advance rapidly. Gas to liquids technology (GTL) provides crystal clear fuels that can dramatically improve air quality in the major metropolitan areas of the world. GTL uses natural gas as a raw material …
- シニア層向け食品のマーケティング差別化Summary How to differentiate Marketing between Aging Consumers and Other Audiences in Food markets shows marketers how they can target the emerging opportunities among an important, under-targeted, and misunderstood consumer group: older consumers. An aging population means the consumption of those aged 55 and over will only grow, and to successfully cater to them, it is important for manufacturer …
- Myopia：グローバル臨床試験レビューH2, 2013Myopia Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Myopia Global Clinical Trials Review, H2, 2013" provides data on the Myopia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myopia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction ac …
